Answers are grounded in this paper and cite their sources.
Patients with multidrug-resistant tuberculosis in Peru and South Africa were randomized to a weight-banded nominal dose of 11, 14, 17, or 20 mg/kg/day levofloxacin (minimum, 750 mg) in combination with other second-line agents. A total of 101 patients were included in noncompartmental pharmacokinetic analyses.
No takes yet. Share an insight, caveat, or question.
Peloquin et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: